ABOUT SMR
The Society for Melanoma Research (SMR) is a diverse organization of scientific and medical investigators devoted to alleviating the suffering of people with Melanoma. The SMR was founded to unify the field by increasing communication among researchers and building bridges of collaboration between basic, translational, and clinical investigators. The Society’s principal goal is bringing together members who vary widely in their professions. Each sharing an abiding devotion to improving the lives of those suffering from this cancer.
ABOUT THE CONGRESS
The Society for Melanoma Research (SMR) is a group of scientists working to find mechanisms responsible for Melanoma and, consequently, new therapies for this specific cancer. SMR fosters collaboration among researchers to advance Melanoma research. This hybrid congress unites global leaders in basic and translational Melanoma research, along with Melanoma clinical trialists. The three-day conference will feature educational and informative sessions related to the growing field of Melanoma research, including pathway-targeted therapies, immunotherapy and other novel approaches to treatment.
Key Dates
Please note, dates are subject to change.
NOVEMBER 20, 2026
Abstract Submission Site Closes.
DECEMBER 16, 2026
Oral and Poster Announcement.
DECEMBER 22, 2026
Early Bird Registration Rate Cut-Off.
FEBRUARY 8, 2027
Late Breaking Abstract Submission Site Closes.
FEBRUARY 28, 2027
Regular Registration Rate Cut-Off.
JANUARY 29, 2027
Late Registration Rate Cut-Off.
Local Organizing Committee
Genevieve Boland, Medical College of Wisconsin
David Fisher, Harvard Medical School
Nir Hacohen, Harvard Medical School
F. Stephen Hodi, Harvard Medical School
Yevgeniy Semenov, Harvard Medical School
Ryan Sullivan, Harvard Medical School